Tag: Nonmerger

Displaying 1 - 20 of 89 results.

Pages

Filtering by content type: Press Release

Today, the Federal Trade Commission filed an amended complaint against Facebook in the agency’s ongoing federal antitrust case. The complaint alleges that after repeated failed attempts to develop innovative mobile features for its network, Facebook instead resorted to an illegal buy-or-bury scheme...
After the Supreme Court declined to review a ruling from the Third Circuit that AbbVie used sham litigation to illegally maintain a monopoly, the Federal Trade Commission has withdrawn the remaining count in its complaint.
The Federal Trade Commission has issued a complaint charging Broadcom with illegally monopolizing markets for semiconductor components used to deliver television and broadband internet services through exclusive dealing and related conduct. The Commission has also issued a proposed consent order ...
The Louisiana Real Estate Appraisers Board has agreed to stop fixing compensation levels for residential real estate appraisal services in Louisiana as part of a settlement reached with the Federal Trade Commission, after the agency alleged that the Board’s conduct violated federal antitrust law.
The Federal Trade Commission has sent a report to Congress about the effects that so-called rebate walls have on competition in markets for pharmaceutical and biopharmaceutical drugs.
The Federal Trade Commission is sending 51,875 payments totaling more than $59 million to consumers who were victims of an allegedly deceptive scheme by Reckitt Benckiser Group and
Following the Federal Trade Commission’s decision not to petition the Supreme Court for review of the Qualcomm case, Acting Chairwoman Rebecca Kelly Slaughter issued this statement:
The FTC is suing Endo Pharmaceuticals Inc., Endo International plc, Impax Laboratories, LLC, and Impax’s owner, Amneal Pharmaceuticals, Inc., alleging that a 2017 agreement between Endo and Impax violated the antitrust laws by eliminating competition in the market for oxymorphone ER. The FTC sued...
The Federal Trade Commission today sued Facebook, alleging that the company is illegally maintaining its personal social networking monopoly through a years-long course of anticompetitive conduct.
The Federal Trade Commission today filed a petition with the U.S. Court of Appeals for the Ninth Circuit requesting rehearing en banc of the August 11, 2020, decision of a panel of that court in the matter of FTC v. Qualcomm Incorporated.
Indivior, Inc. has agreed to pay $10 million to settle Federal Trade Commission charges that it violated antitrust laws through a deceptive scheme to thwart lower priced generic competition with its branded opioid replacement therapy drug Suboxone. The proposed stipulated order for a permanent...
Following a public comment period, the Federal Trade Commission has approved final orders settling charges that rent-to-own operators Aaron’s Inc., Buddy’s Newco, LLC,  and Rent-A-Center, Inc. negotiated and executed reciprocal purchase agreements in violation of federal an
The staff of Federal Trade Commission’s Office of Policy Planning, Bureau of Economics, and Bureau of Competition, together with the staff of the Antitrust Division of the Department of Justice, have submitted a letter to California State Assembly Member Jim Wood raising concerns that California...
Rent-to-own operators Aaron’s Inc., Buddy’s Newco, LLC, and Rent-A-Center, Inc. have agreed to settle FTC charges that they negotiated and executed reciprocal purchase agreements in violation of federal antitrust law.
After Chief Administrative Law Judge D. Michael Chappell held in his Initial Decision that two of three respondents named in a Federal Trade Commission complaint violated U.S. antitrust laws, those companies have declined to appeal the decision to the federal district court.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that a Texas company providing therapist staffing services to home health agencies, its owner, and the former owner of a competitor agreed to reduce pay rates for therapists and invited other...
Reckitt Benckiser Group plc has agreed to pay $50 million to settle Federal Trade Commission charges that it violated the antitrust laws through a deceptive scheme to thwart lower-priced generic competition to its branded drug Suboxone. Suboxone is a prescription oral medication used to minimize...
Federal Trade Commission Bureau of Competition Director Bruce Hoffman issued this statement regarding the U.S. District Court for the Northern District of California’s ruling yesterday that Qualcomm Inc.’s licensing practices relating to its modem chips violate Sections 1 and 2 of the Sherman Act...
The Federal Trade Commission sued the health information company Surescripts, alleging that the company employed illegal vertical and horizontal restraints in order to maintain its monopolies over two electronic prescribing, or “e-prescribing,” markets: routing and eligibility.
The Federal Trade Commission has reached a settlement in FTC v. Actavis, the 2009 FTC case alleging that the brand-name drug company Solvay and three generic drug companies illegally agreed to restrict generic competition to Solvay’s branded testosterone-replacement drug AndroGel for nine years.

Pages